Drug intelligence / Profile preview

Qingchang Ligan

Development stage
Preclinical
Lead developer
Beijing Tong Ren Tang
Modality
Small Molecules
Administration
Oral
01

Overview

Qingchang Ligan (QCLG) is a traditional Chinese medicine (TCM) herbal formulation composed of five botanical ingredients in a 2:1:1:1:1 ratio. The herbs are Rheum palmatum (Rheum Radix et Rhizoma), Rehmannia glutinosa (Rehmanniae Radix), Magnolia officinalis (Magnoliae Officinalis Cortex), Citrus aurantium (Aurantii Fructus), and Taraxacum mongolicum (Taraxaci Herba)[9]. It is primarily used for the treatment of liver failure and hepatic encephalopathy. Preclinical studies demonstrate that QCLG exerts hepatoprotective effects by attenuating liver inflammation, reducing hepatocyte apoptosis, modulating the mitogen-activated protein kinase pathway, promoting autophagy[1], and regulating gut microbiota composition[6][9]. In animal models of acute liver failure and hepatic encephalopathy, QCLG improved survival rates, reduced inflammatory cytokine levels such as TNF-α, IL-1β, and IL-6[6][9], restored gut microbial balance disrupted by liver injury or toxins[9], and ameliorated cognitive impairment associated with hepatic encephalopathy.

Brand names
Qingchang Ligan
Other names
Qingchangligan formulaQCLG formula清肠利肝方
02

Targets

IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Qingchang Ligan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingchang Ligan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call